Early detection and staging of lung cancer is important in initiating rapid treatment and
improving prognosis. Computed tomography (CT) and magnetic resonance (MR) imaging …

Positron emission tomography (PET) originally was a research tool for brain function and
cardiac metabolism studies. In the past decade, metabolic imaging with PET has become an …

Since its introduction in 1974, positron emission tomography (PET) has gained widespread
use, especially in diagnosis and staging of lung cancer. In this respect, 18F …

Carcinoma of the lung is one of the most frequent malignancies and a major cause of
mortality. The use of positron emission tomography (PET) has been extensively investigated …

Positron emission tomography (PET)/computed tomographic scanning, using 18F-2-deoxy-
D-glucose, complements conventional imaging evaluation of patients with lung cancer. The …

18 FDG-PET is an imagining technique based on metabolic criteria rather than
morphological criteria.(18) FDG-PET can demonstrate accelerated glycosis in cancer tissue …

The availability of clinical positron emission tomography (PET) is increasing rapidly in the
developed world (1). This article reviews the role of PET scanning in lung cancer …

Opinion statement The dissemination of positron emission tomography (PET) technology
has enabled a functional approach to the evaluation of lung cancer that complements the …

Lung cancer is the leading cause of cancer mortality in the United States, with more than
170,000 individuals diagnosed each year and more than 140,000 succumbing to the …

Lung cancer is the second most common cancer and the leading cause of cancer-related
deaths. 2-deoxy-2-(18 F) fluoro-D-glucose (FDG) positron emission tomography (PET) fused …